Lawrence Long, MCom, PhD
Research Assistant Professor
Boston University School of Public Health
Dept of Global Health

PhD, University of the Witwatersrand
M.Com., University of the Witwatersrand
B.Bus.Sci., University of Cape Town

Lawrence Long (MCom, PhD) is a health economist and public health policy researcher. He is a Research Assistant Professor at the Boston University School of Public Health and holds a joint appointment at the University of Witwatersrand (Johannesburg, South Africa). He has more than 14 years of experience conducting applied research on the economic impact of HIV, tuberculosis and associated conditions within South Africa and sub-Saharan Africa. Prior to his appointment at Boston University he led a growing South African research group as the deputy director and has extensive experience in organizational management, leadership and grant management. Lawrence did his undergraduate degree in business science with a specialization in economics and finance and then went on to focus on economics and its application to public health in his graduate studies. Currently he is a co-PI of a number of HIV projects under a multi-year USAID co-operative agreement in South Africa and a co-investigator on a Gates award to evaluate the roll out of differentiated HIV service delivery in selected countries in Africa. In addition to this he is expanding his work to start looking at HIV prevention, in particular amongst key populations in resource limited settings.
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Evans D, Sineke T, Schnippel K, Berhanu R, Govathson C, Black A, Long L, Rosen S. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Serv Res. 2018 Dec 17; 18(1):973.View Related Profiles. PMID: 30558670; DOI: 10.1186/s12913-018-3762-x;.
  2. Onoya D, Hirasen K, van den Berg L, Miot J, Long LC, Fox MP. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa. Drug Saf. 2018 12; 41(12):1343-1353.View Related Profiles. PMID: 30043384.
  3. Hirasen K, Berhanu R, Evans D, Rosen S, Sanne I, Long L. High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa. PLoS One. 2018; 13(10):e0205463.View Related Profiles. PMID: 30300403.
  4. Brennan AT, Jamieson L, Crowther NJ, Fox MP, George JA, Berry KM, Stokes A, Maskew M, Sanne I, Long L, Cassim N, Rosen S. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa. PLoS One. 2018; 13(10):e0204020.View Related Profiles. PMID: 30281618.
  5. Long LC, Evans D, Rosen S, Sauls C, Brennan AT, Sanne IM, Fox MP. Can routine inpatient mortality data improve HIV mortality estimates? Inpatient mortality at an urban hospital in South Africa. S Afr Med J. 2018 Oct 02; 108(10):870-875.View Related Profiles. PMID: 30421717.
  6. Hendrickson CJ, Pascoe SJS, Huber AN, Moolla A, Maskew M, Long LC, Fox MP. "My future is bright…I won't die with the cause of AIDS": ten-year patient ART outcomes and experiences in South Africa. J Int AIDS Soc. 2018 Oct; 21(10):e25184.View Related Profiles. PMID: 30318848.
  7. Shearer K, Evans D, Xhosa B, Hirasen K, Bracken C, Mahomed K, Long L, Fox MP. Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa. PLoS One. 2018; 13(9):e0203797.View Related Profiles. PMID: 30252844; DOI: 10.1371/journal.pone.0203797;.
  8. Maskew M, Jamieson L, Mohomi G, Long L, Mongwenyana C, Nyoni C, Mokaba D, Fox MP, Sanne I, Rosen S. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care. PLoS One. 2018; 13(8):e0201955.View Related Profiles. PMID: 30161147.
  9. Bonawitz R, Brennan AT, Long L, Heeren T, Maskew M, Sanne I, Fox MP. Regimen durability in HIV-infected children and adolescents initiating first-line antiretroviral therapy in a large public sector HIV cohort in South Africa. Trop Med Int Health. 2018 06; 23(6):650-660.View Related Profiles. PMID: 29656449.
  10. Evans D, Musakwa N, Nattey C, Bor J, Lönnermark E, Nyasulu P, Long L. Knowledge, risk perception and barriers to accessing care for HIV and Tuberculosis among adolescents and young adults aged 18 – 25 years in Johannesburg, South Africa. The South African Journal of Child Health. 2018; 2018(Special):S19-S31. View Publication
Showing 10 of 65 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 65 publications over 10 distinct years, with a maximum of 16 publications in 2016

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Health Economics
Economic Evaluation
Cost Analysis
Cost Effectiveness Analysis
South Africa
Contact for Mentoring:

801 Massachusetts Avenue, Crosstown Center CT369
Boston MA 02118
Google Map

Long's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department